Gastrin and Gastric Cancer

por Smith, Jill P., Nadella, Sandeep, Osborne, Nick
Publicado 2017

The Role of Gastrin and CCK Receptors in Pancreatic Cancer and other Malignancies

por Smith, Jill P., Fonkoua, Lionel K., Moody, Terry W.
Publicado 2016

Therapeutic Effect of Vitamin D Supplementation in a Pilot Study of Crohn's Patients

por Yang, Linlin, Weaver, Veronika, Smith, Jill P, Bingaman, Sandra, Hartman, Terryl J, Cantorna, Margherita T
Publicado 2013

Cholecystokinin-B Receptor-Targeted Nanoparticle for Imaging and Detection of Precancerous Lesions in the Pancreas

por Smith, Jill P., Cao, Hong, Edmondson, Elijah F., Dasa, Siva Sai Krishna, Stern, Stephan T.
Publicado 2021

25380 Cholecystokinin-B Receptor -Mediates Growth of Hepatocellular Carcinoma

por Gay, Martha Dee, Safronenka, Anita, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Smith, Jill P.
Publicado 2021

Cholecystokinin Receptor Antagonist Induces Pancreatic Stellate Cell Plasticity Rendering the Tumor Microenvironment Less Oncogenic

por Jolly, Gurbani, Duka, Tetyana, Shivapurkar, Narayan, Chen, Wenqiang, Bansal, Sunil, Cheema, Amrita, Smith, Jill P.
Publicado 2023

Gastrin Vaccine Alone and in Combination With an Immune Checkpoint Antibody Inhibits Growth and Metastases of Gastric Cancer

por Smith, Jill P., Cao, Hong, Chen, Wenqiang, Mahmood, Kanwal, Phillips, Teresa, Sutton, Lynda, Cato, Allen
Publicado 2021

4121 The beneficial, anti-fibrotic effects of chemokine receptor 2 and 5 antagonists on fat-exposed mouse primary hepatic stellate cells (pHSCs)

por Kruger, Annie J., Bergman, Kruger, Gay, Martha, Cao, Hong, Tucker, Robin, Shivapurkar, Narayan, Smith, Jill P.
Publicado 2020

Germline Mutation of the CCK Receptor: A Novel Biomarker for Pancreas Cancer

por Alsubai, Jelal, Matters, Gail L, McGovern, Christopher O, Liao, Jiangang, Gilius, Evan L, Smith, Jill P
Publicado 2016

Proglumide Reverses Nonalcoholic Steatohepatitis by Interaction with the Farnesoid X Receptor and Altering the Microbiome

por Gay, Martha D., Cao, Hong, Shivapurkar, Narayan, Dakshanamurthy, Sivanesan, Kallakury, Bhaskar, Tucker, Robin D., Kwagyan, John, Smith, Jill P.
Publicado 2022

Effect of liver histopathology on islet cell engraftment in the model mimicking autologous islet cell transplantation

por Desai, Chirag S., Khan, Khalid M., Ma, Xiaobo, Li, Henghong, Wang, Juan, Fan, Lijuan, Chen, Guoling, Smith, Jill P., Cui, Wanxing
Publicado 2017

Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer

por Burks, Julian, Nadella, Sandeep, Mahmud, Abdullah, Mankongpaisarnrung, Charoen, Wang, Juan, Hahm, Jong-In, Tucker, Robin D., Shivapurkar, Narayan, Stern, Stephan T., Smith, Jill P.
Publicado 2018

Safety and Pharmacokinetic Assessment of Oral Proglumide in Those with Hepatic Impairment

por Hsu, Christine C., Bansal, Sunil, Cao, Hong, Smith, Coleman I., He, Aiwu Ruth, Gay, Martha D., Li, Yaoxiang, Cheema, Amrita, Smith, Jill P.
Publicado 2022

Target-Specific Nanoparticle Polyplex Down-Regulates Mutant Kras to Prevent Pancreatic Carcinogenesis and Halt Tumor Progression

por Smith, Jill P., Chen, Wenqiang, Shivapurkar, Narayan, Gerber, Monica, Tucker, Robin D., Kallakury, Bhaskar, Dasa, Siva Sai Krishna, Kularatne, Ruvanthi N., Stern, Stephan T.
Publicado 2023

Treatment with a Cholecystokinin Receptor Antagonist, Proglumide, Improves Efficacy of Immune Checkpoint Antibodies in Hepatocellular Carcinoma

por Shivapurkar, Narayan, Gay, Martha D., He, Aiwu (Ruth), Chen, Wenqiang, Golnazar, Shermineh, Cao, Hong, Duka, Tetyana, Kallakury, Bhaskar, Vasudevan, Sona, Smith, Jill P.
Publicado 2023

Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment

por Malchiodi, Zoe X., Cao, Hong, Gay, Martha D., Safronenka, Anita, Bansal, Sunil, Tucker, Robin D., Weinberg, Benjamin A., Cheema, Amrita, Shivapurkar, Narayan, Smith, Jill P.
Publicado 2021

Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis

por Rabiee, Atoosa, Gay, Martha D., Shivapurkar, Narayan, Cao, Hong, Nadella, Sandeep, Smith, Coleman I., Lewis, James H., Bansal, Sunil, Cheema, Amrita, Kwagyan, John, Smith, Jill P.
Publicado 2022

A Cholecystokinin Receptor Antagonist Halts Nonalcoholic Steatohepatitis and Prevents Hepatocellular Carcinoma

por Tucker, Robin D., Ciofoaia, Victor, Nadella, Sandeep, Gay, Martha D., Cao, Hong, Huber, Matthew, Safronenka, Anita, Shivapurkar, Narayan, Kallakury, Bhaskar, Kruger, Annie J., Kroemer, Alexander H. K., Smith, Jill P.
Publicado 2019

A Cholecystokinin B Receptor-Specific DNA Aptamer for Targeting Pancreatic Ductal Adenocarcinoma

por Clawson, Gary A., Abraham, Thomas, Pan, Weihua, Tang, Xiaomeng, Linton, Samuel S., McGovern, Christopher O., Loc, Welley S., Smith, Jill P., Butler, Peter J., Kester, Mark, Adair, James H., Matters, Gail L.
Publicado 2017

TGFβ Drives Metabolic Perturbations during Epithelial Mesenchymal Transition in Pancreatic Cancer: TGFβ Induced EMT in PDAC

por Rajagopal, Meena U., Bansal, Shivani, Kaur, Prabhjit, Jain, Shreyans K., Altadil, Tatiana, Hinzman, Charles P., Li, Yaoxiang, Moulton, Joanna, Singh, Baldev, Bansal, Sunil, Chauthe, Siddheshwar Kisan, Singh, Rajbir, Banerjee, Partha P., Mapstone, Mark, Fiandaca, Massimo S., Federoff, Howard J., Unger, Keith, Smith, Jill P., Cheema, Amrita K.
Publicado 2021